Grytten N, Myhr K-M, Celius E, et al. Cancer risk in multiple sclerosis patients, siblings, and healthy controls: a prospective, longitudinal cohort study. 5th European Academy of Neurology (EAN) Congress. Abstract O1204.
Vergoeding selumetinib (Koselugo) voor kinderen met neurofibromatose type 1
mei 2024